12399456https://www.upal.com.my/zh/feeds/jobFeedKwongwahArray ( [0] => HTTP/1.1 200 OK [1] => Date: Sun, 06 Apr 2025 08:54:27 GMT [2] => Content-Type: text/xml; charset=utf-8 [3] => Connection: close [4] => Server: cloudflare [5] => Nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800} [6] => Vary: Accept-Encoding [7] => X-Powered-By: PHP/7.4.33 [8] => Cache-Control: no-cache, private [9] => Cf-Ray: 92c00f833ef7dd9d-HKG [10] => X-Frame-Options: SAMEORIGIN [11] => X-Xss-Protection: 1; mode=block [12] => X-Content-Type-Options: nosniff [13] => Referrer-Policy: no-referrer-when-downgrade [14] => Cf-Cache-Status: DYNAMIC [15] => Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v4?s=VciRR%2FjTv66NuQW7v1k4%2FkmskBxteFKtX0%2BJCL6RKS8H0h4a9gQGtPtt%2BxmBSvK3owhep67ysg0cD8r9fZ0uX6dfRghKd9iIpe5K9Do3jcTPZnm3svYE2ypnI0%2Fjw57tr58%3D"}],"group":"cf-nel","max_age":604800} [16] => Set-Cookie: UpalLiveSession=eyJpdiI6ImR3emVBQnQ2YU9ZdTE5bGl0RHRVVlE9PSIsInZhbHVlIjoiUmdtc2E3aXRWYTZGTlNNRmZoNmJKem9DTTRKV21pQ09zVkZhdEl1WU1uOTYrTUlMczM3NERUekhWZjZtQ0lXYzFFelU1TXRxZU02SnpRa2tnRmdtWHc9PSIsIm1hYyI6IjhmODE3NDY3ZjNmY2RlYzhjYmNiNTk2NTUxNWQzMTkzMTFjZTY2YTc3NjJmYTZjMmVhZTY3MDFjY2ZlNjhjODQifQ%3D%3D; HttpOnly; Path=/; Max-Age=94608000; Expires=Wed, 05 Apr 2028 08:41:52 GMT [17] => alt-svc: h3=":443"; ma=86400 [18] => server-timing: cfL4;desc="?proto=TCP&rtt=45744&min_rtt=45642&rtt_var=12908&sent=5&recv=6&lost=0&retrans=0&sent_bytes=3002&recv_bytes=756&delivery_rate=63450&cwnd=104&unsent_bytes=0&cid=bbaffe8aad48a6ee&ts=231&x=0" ) 789

 

 

季度营业额创新高及联号公司提高贡献，把柔佛医药保健（KPJ，5878，医疗保健组）截至今年9月杪第3季（2019财年第3季）净利推高12.38%至4641万令吉，上财年同季报4130万令吉。

大马与印尼业务报捷，刺激季度营业额增长10.47%至9亿零644万令吉，一年前为8亿2056万令吉。

每股盈利从0.99仙，增至1.10仙。

该集团宣布，派发每股0.5仙中期股息，将于2020年2月14日支付。

该集团在现财年首9个月净赚1亿2737万令吉，较一年前的1亿2612万令吉，微扬0.99%。

现财年首3季营业额增加7.24%至26亿2000万令吉，上财年同期报24亿4000万令吉。

“集团有信心2019财政年业绩有所改善，并预计在成本挑战不断加剧的情况下，可维持扣除利息、税项、折旧及摊销前盈利（EBITDA）和税前赚幅。”

---

// // // //